Leucht, Stefan

Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysis

Leucht, S., Schneider‐Thoma, J., Burschinski, A., Peter, N., Wang, D., Dong, S., Huhn, M., Nikolakopoulou, A., Salanti, G., & Davis, J. M. (2023) · World Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 78

“How to Speak to Your Psychiatrist”: Shared Decision-Making Training for Inpatients With Schizophrenia

Hamann, J., Mendel, R., Meier, A., Asani, F., Pausch, E., Leucht, S., & Kissling, W. (2011) · Psychiatric Services

Patient-Provider Communication in HealthcareMental Health and Patient Involvement

Cited by 76

Caregivers of patients with frontotemporal lobar degeneration: a review of burden, problems, needs, and interventions

Nunnemann, S., Kurz, A., Leucht, S., & Diehl-Schmid, J. (2012) · International Psychogeriatrics

Dementia and Cognitive Impairment ResearchNursing care and research

Cited by 75

Metformin for the prevention of antipsychotic-induced weight gain: guideline development and consensus validation

Carolan, A., Hynes-Ryan, C., Agarwal, S. M., Bourke, R., Cullen, W., Gaughran, F., Hahn, M. K., Krivoy, A., Lally, J., Leucht, S., et al. (2025) · Schizophrenia Bulletin

Schizophrenia research and treatmentPharmacology and Obesity Treatment

Cited by 70

Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis

Zhu, Y., Zhang, C., Siafis, S., Zhuo, K., Zhu, D., Wu, H., Liu, D., Jiang, K., Wang, J., Leucht, S., et al. (2021) · Schizophrenia Research

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 69

A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia

Dong, S., Schneider-Thoma, J., Bighelli, I., Siafis, S., Wang, D., Burschinski, A., Schestag, K., Samara, M., & Leucht, S. (2024) · European Archives of Psychiatry and Clinical Neuroscience

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 68

Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: A systematic review, pairwise and network meta-analysis

Krause, M., Gutsmiedl, K., Bighelli, I., Schneider-Thoma, J., Chaimani, A., & Leucht, S. (2019) · European Neuropsychopharmacology

Treatment of Major DepressionMental Health Treatment and Access

Cited by 65

Psychiatrists’ attitude to antipsychotic depot treatment in patients with first-episode schizophrenia

Heres, S., Reichhart, T., Hamann, J., Mendel, R., Leucht, S., & Kissling, W. (2011) · European Psychiatry

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 64

Clinical relevance of findings in trials of CBT for depression

Lepping, P., Whittington, R., Sambhi, R. S., Lane, S., Poole, R., Leucht, S., Cuijpers, P., McCabe, R., & Waheed, W. (2017) · European Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 60

Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysis

Wang, D., Schneider-Thoma, J., Siafis, S., Qin, M., Wu, H., Zhu, Y., Davis, J. M., Priller, J., & Leucht, S. (2024) · European Neuropsychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 44

Modeling Determinants of Medication Attitudes and Poor Adherence in Early Nonaffective Psychosis: Implications for Intervention

Drake, R. J., Nordentoft, M., Haddock, G., Arango, C., Fleischhacker, W. W., Glenthøj, B., Leboyer, M., Leucht, S., Leweke, M., McGuire, P., et al. (2015) · Schizophrenia Bulletin

Schizophrenia research and treatmentMedication Adherence and Compliance

Cited by 42

Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis

Smith, R. C., Leucht, S., & Davis, J. M. (2019) · Psychopharmacology

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 41

Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis

Takeuchi, H., MacKenzie, N. E., Samaroo, D., Agid, O., Remington, G., & Leucht, S. (2020) · Schizophrenia Bulletin

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 39

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial

Huhn, M., Leucht, C., Rothe, P., Dold, M., Heres, S., Bornschein, S., Schneider-Axmann, T., Hasan, A., & Leucht, S. (2021) · European Archives of Psychiatry and Clinical Neuroscience

Schizophrenia research and treatmentBipolar Disorder and Treatment

Cited by 38

Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis

Zhou, X., Cipriani, A., Zhang, Y., Cuijpers, P., Hetrick, S. E., Weisz, J. R., Pu, J., Giovane, C. D., Furukawa, T. A., Barth, J., et al. (2017) · BMJ Open

Treatment of Major DepressionChild and Adolescent Psychosocial and Emotional Development

Cited by 31

Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials

Wang, D., Schneider-Thoma, J., Siafis, S., Burschinski, A., Dong, S., Wu, H., Zhu, Y., Davis, J. M., Priller, J., & Leucht, S. (2024) · Schizophrenia Bulletin

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 29

No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review

Furukawa, T. A., Salanti, G., Cowen, P. J., Leucht, S., & Cipriani, A. (2020) · Acta Psychiatrica Scandinavica

Treatment of Major DepressionMental Health Treatment and Access

Cited by 26

Tool to assess risk of bias in studies estimating the prevalence of mental health disorders (RoB-PrevMH)

Tonia, T., Buitrago-Garcia, D., Peter, N. L., Mesa-Vieira, C., Li, T., Furukawa, T. A., Cipriani, A., Leucht, S., Low, N., & Salanti, G. (2023) · BMJ Mental Health

Meta-analysis and systematic reviewsStatistical Methods in Epidemiology

Cited by 26

Negative symptoms, striatal dopamine and model-free reward decision-making in schizophrenia

Brandl, F., Knolle, F., Avram, M., Leucht, C., Yakushev, I., Priller, J., Leucht, S., Ziegler, S., Wunderlich, K., & Sorg, C. (2023) · Brain

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 24

Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review

Furukawa, T. A., Miura, T., Chaimani, A., Leucht, S., Cipriani, A., Noma, H., Mitsuyasu, H., Kanba, S., & Salanti, G. (2016) · BMC Research Notes

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 23

What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial

Czobor, P., Sebe, B., Acsai, K., Barabássy, Á., Laszlovszky, I., Németh, G., Furukawa, T. A., & Leucht, S. (2022) · Frontiers in Psychiatry

Schizophrenia research and treatmentStatistical Methods in Clinical Trials

Cited by 20

About the issue of including or excluding studies from China in systematic reviews

Leucht, S., Li, C., Davis, J. M., Bighelli, I., Zhu, Y., & Furukawa, T. A. (2022) · Schizophrenia Research

Meta-analysis and systematic reviewsSchizophrenia research and treatment

Cited by 16